What a drug study keeps here
Protocol and amendment versions. Eligibility, visits, and endpoints. Adverse events with seriousness, causality, and expectedness. Safety reporting timed for CTIS or for an IND. Estimands when the analysis estimates a treatment effect. Listings, tables, and figures that name the snapshot they came from. SDTM and ADaM are in the target so an eCTD package can be produced without retyping the trial.